Stock HLS HLS THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders HLS Therapeutics Inc.

Equities

HLS

CA40390B1094

Market Closed - Toronto S.E.
Other stock markets
 02:10:40 2024-05-30 pm EDT 		5-day change 1st Jan Change
3.72 CAD -7.00% Intraday chart for HLS Therapeutics Inc. -4.12% -5.82%
May. 28 HLS Therapeutics Notes Role of Pharmaceutical Support Programs on Persistence with Clozapine Treatment in Quebec Study MT
May. 28 HLS Therapeutics Inc. Announces New Study Published on the Impact of Pharmaceutical Support Programs on Persistence with Clozapine Treatment CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HLS Therapeutics Announcing CFO Departure; John Hanna appointed Interim CFO to replace departing CFO Tim Hendrickson
MT
HLS Therapeutics Brief: Announcing CFO Departure; John Hanna appointed Interim CFO to replace departing CFO Tim Hendrickson
MT
HLS Therapeutics Brief: John Welborn, Jr. Appointed Chair of the Board, Succeeding Greg Gubitz, who is Retiring; John Hanna Appointed as an independent director
MT
HLS Therapeutics Inc. Announces Board Changes
CI
HLS Therapeutics Inc. Elects Christian Roy as Director
CI
HLS Therapeutics Up 3% As Announces Retirement Of 2 Board Directors, Strikes Agreement with Polar Asset Management Partners
MT
Hls Therapeutics Inc. Announces Resignation of Director
CI
HLS Therapeutics Announces Retirement Of 2 Board Directors, Strikes Agreement with Polar Asset Management Partners
MT
HLS Therapeutics Announcing CEO Transition; Craig Millian to Replace Retiring CEO, Gilbert Godin, on May 1, 2023
MT
HLS Therapeutics Inc. Announces Board Changes
CI
HLS Therapeutics Inc. Announces Chief Executive Officer Changes
CI
HLS Therapeutics Inc. Appoints Kyle Dempsey as Independent Director
CI
HLS Therapeutics Executive Chair Bill Wells Retires, Gubitz to Become Board Chair
MT
HLS Therapeutics Inc. Announces Board Changes
CI
HLS Therapeutics Inc. Announces Board Appointments
CI
HLS Therapeutics Announces Executive Changes
CI
HLS Therapeutics Inc. Announces Board Changes
CI
HLS Therapeutics Inc. Appoints Tim Hendrickson to the Role of Chief Financial Officer
CI
HLS Therapeutics Inc. Appoints Ryan C. Lennox as General Counsel
CI
HLS Therapeutics Inc Announces Appointment of Independent Directors
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HLS Stock
  4. News HLS Therapeutics Inc.
  5. Insiders